CN112458026A - Bacillus subtilis capable of efficiently degrading vomitoxin and application thereof - Google Patents
Bacillus subtilis capable of efficiently degrading vomitoxin and application thereof Download PDFInfo
- Publication number
- CN112458026A CN112458026A CN202011470276.8A CN202011470276A CN112458026A CN 112458026 A CN112458026 A CN 112458026A CN 202011470276 A CN202011470276 A CN 202011470276A CN 112458026 A CN112458026 A CN 112458026A
- Authority
- CN
- China
- Prior art keywords
- bacillus subtilis
- vomitoxin
- sterile
- soil
- strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- LINOMUASTDIRTM-QGRHZQQGSA-N deoxynivalenol Chemical compound C([C@@]12[C@@]3(C[C@@H](O)[C@H]1O[C@@H]1C=C(C([C@@H](O)[C@@]13CO)=O)C)C)O2 LINOMUASTDIRTM-QGRHZQQGSA-N 0.000 title claims abstract description 90
- LINOMUASTDIRTM-UHFFFAOYSA-N vomitoxin hydrate Natural products OCC12C(O)C(=O)C(C)=CC1OC1C(O)CC2(C)C11CO1 LINOMUASTDIRTM-UHFFFAOYSA-N 0.000 title claims abstract description 90
- 244000063299 Bacillus subtilis Species 0.000 title claims abstract description 40
- 235000014469 Bacillus subtilis Nutrition 0.000 title claims abstract description 40
- 230000000593 degrading effect Effects 0.000 title claims abstract description 23
- 239000002689 soil Substances 0.000 claims abstract description 33
- 238000012216 screening Methods 0.000 claims abstract description 16
- 241000209140 Triticum Species 0.000 claims abstract description 10
- 235000021307 Triticum Nutrition 0.000 claims abstract description 10
- 230000015556 catabolic process Effects 0.000 claims abstract description 9
- 238000006731 degradation reaction Methods 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 239000001963 growth medium Substances 0.000 claims description 23
- 230000001580 bacterial effect Effects 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 17
- 239000002895 emetic Substances 0.000 claims description 16
- 239000003053 toxin Substances 0.000 claims description 16
- 231100000765 toxin Toxicity 0.000 claims description 16
- 238000000855 fermentation Methods 0.000 claims description 15
- 230000004151 fermentation Effects 0.000 claims description 15
- 238000012360 testing method Methods 0.000 claims description 12
- 238000005070 sampling Methods 0.000 claims description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 9
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 9
- 235000005822 corn Nutrition 0.000 claims description 9
- 239000003085 diluting agent Substances 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- 239000000243 solution Substances 0.000 claims description 9
- 239000008223 sterile water Substances 0.000 claims description 9
- 239000012153 distilled water Substances 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 238000012258 culturing Methods 0.000 claims description 7
- 201000010099 disease Diseases 0.000 claims description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 7
- 210000005253 yeast cell Anatomy 0.000 claims description 7
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 6
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 6
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 6
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 6
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical class O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 claims description 6
- 210000004027 cell Anatomy 0.000 claims description 6
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 6
- 229910000397 disodium phosphate Inorganic materials 0.000 claims description 6
- 235000013312 flour Nutrition 0.000 claims description 6
- 241000894007 species Species 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 claims description 5
- 239000002609 medium Substances 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- 229920001817 Agar Polymers 0.000 claims description 3
- 239000001888 Peptone Substances 0.000 claims description 3
- 108010080698 Peptones Proteins 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 239000008272 agar Substances 0.000 claims description 3
- 102000004139 alpha-Amylases Human genes 0.000 claims description 3
- 108090000637 alpha-Amylases Proteins 0.000 claims description 3
- 229940024171 alpha-amylase Drugs 0.000 claims description 3
- 239000001110 calcium chloride Substances 0.000 claims description 3
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 3
- 229940041514 candida albicans extract Drugs 0.000 claims description 3
- 238000010790 dilution Methods 0.000 claims description 3
- 239000012895 dilution Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 235000019319 peptone Nutrition 0.000 claims description 3
- 239000004033 plastic Substances 0.000 claims description 3
- 238000011218 seed culture Methods 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 239000010902 straw Substances 0.000 claims description 3
- 239000002344 surface layer Substances 0.000 claims description 3
- 239000012138 yeast extract Substances 0.000 claims description 3
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 claims 2
- 206010039509 Scab Diseases 0.000 abstract 1
- 229930002954 deoxynivalenol Natural products 0.000 description 33
- 239000000523 sample Substances 0.000 description 14
- 231100000678 Mycotoxin Toxicity 0.000 description 12
- 239000002636 mycotoxin Substances 0.000 description 12
- 108700012359 toxins Proteins 0.000 description 11
- 241000209149 Zea Species 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 235000014590 basal diet Nutrition 0.000 description 9
- 235000021050 feed intake Nutrition 0.000 description 8
- 238000001179 sorption measurement Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 235000013339 cereals Nutrition 0.000 description 7
- 230000037396 body weight Effects 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 238000001784 detoxification Methods 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 235000019786 weight gain Nutrition 0.000 description 6
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 5
- 241000223218 Fusarium Species 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000003463 adsorbent Substances 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- 239000012224 working solution Substances 0.000 description 4
- 238000003794 Gram staining Methods 0.000 description 3
- 240000005979 Hordeum vulgare Species 0.000 description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- OQIQSTLJSLGHID-WNWIJWBNSA-N aflatoxin B1 Chemical compound C=1([C@@H]2C=CO[C@@H]2OC=1C=C(C1=2)OC)C=2OC(=O)C2=C1CCC2=O OQIQSTLJSLGHID-WNWIJWBNSA-N 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 101100449517 Arabidopsis thaliana GRH1 gene Proteins 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 241000223195 Fusarium graminearum Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 101100434479 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) AFB1 gene Proteins 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 229930020125 aflatoxin-B1 Natural products 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000004913 chyme Anatomy 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000001506 immunosuppresive effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000000844 transformation Methods 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- ADFIQZBYNGPCGY-HTJQZXIKSA-N 3-acetyldeoxynivalenol Chemical compound C([C@]12[C@]3(C)C[C@H]([C@H]2O[C@H]2[C@@]3([C@H](O)C(=O)C(C)=C2)CO)OC(=O)C)O1 ADFIQZBYNGPCGY-HTJQZXIKSA-N 0.000 description 1
- IDGRYIRJIFKTAN-UHFFFAOYSA-N 3-acetyldeoxynivalenol Natural products CC(=O)OCC12C(O)C(=O)C(C)=CC1OC1C(O)CC2(C)C11CO1 IDGRYIRJIFKTAN-UHFFFAOYSA-N 0.000 description 1
- ADFIQZBYNGPCGY-UHFFFAOYSA-N Acetyldeoxynivalenol Natural products C1=C(C)C(=O)C(O)C2(CO)C1OC1C(OC(=O)C)CC2(C)C21CO2 ADFIQZBYNGPCGY-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241001619326 Cephalosporium Species 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000223221 Fusarium oxysporum Species 0.000 description 1
- 241000508192 Fusarium oxysporum f. sp. niveum Species 0.000 description 1
- 241000221779 Fusarium sambucinum Species 0.000 description 1
- 241000223192 Fusarium sporotrichioides Species 0.000 description 1
- 241000233732 Fusarium verticillioides Species 0.000 description 1
- 229930191978 Gibberellin Natural products 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000223259 Trichoderma Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 231100000570 acute poisoning Toxicity 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001887 anti-feedant effect Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 description 1
- 239000003448 gibberellin Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000000777 hematopoietic system Anatomy 0.000 description 1
- 238000000703 high-speed centrifugation Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229930013292 trichothecene Natural products 0.000 description 1
- LZAJKCZTKKKZNT-PMNGPLLRSA-N trichothecene Chemical compound C12([C@@]3(CC[C@H]2OC2C=C(CCC23C)C)C)CO1 LZAJKCZTKKKZNT-PMNGPLLRSA-N 0.000 description 1
- 125000000210 trichothecene group Chemical class [H][C@]12O[C@]3([H])[C@H]([*])[C@@H]([*])[C@@](C)(C33CO3)C1(C[*])C([*])C([*])C(C)=C2 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/28—Silicates, e.g. perlites, zeolites or bentonites
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
- A23L5/28—Removal of unwanted matter, e.g. deodorisation or detoxification using microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/02—Separating microorganisms from their culture media
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Animal Husbandry (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- Nutrition Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a bacillus subtilis AM-05 strain for efficiently degrading vomitoxin, which is obtained by separating, screening and fermenting the bacillus subtilis AM-05 strain in wheat field soil infected with scab, and has good stability and high degradation rate when being applied to DON degradation.
Description
Technical Field
The invention relates to bacillus subtilis AM-05 for efficiently degrading vomitoxin and application thereof, belonging to the field of biological feed additives in biological agriculture.
Background
The main component of vomitoxin is DON (deoxynivalenol), belongs to trichothecene compounds, and is mainly produced by fusarium graminearum, fusarium oxysporum, fusarium moniliforme, fusarium sporotrichioides, fusarium roseum, fusarium niveum and other fusarium. In addition, strains of the genus cephalosporium, the genus painterl, the genus trichoderma, etc. can produce the toxin. The trichothecene toxins are over 150 kinds, are strong immunosuppressants, and cause the typical symptom that the feed intake is reduced, so the toxins are also called as feed antifeedant toxins. Vomitoxin (DON) is one of the most important toxins, mainly from Fusarium, especially Fusarium graminearum and Fusarium yellow, also known as vomitoxin (vomitoxin, VT) because it can cause vomiting in pigs.
The toxin was first discovered in 1970 in a virus poisoned by primary gibberellic barley in Xiangchuan county of Japan, and in 1972, it was first isolated from gibberellic barley by Morooka et al, Japan, and Yoshizawa et al elucidated the structure of this novel mycotoxin and named 4-Deoxynivalenol (DON). The same chemical was isolated in 1973 by vesoder et al in the united states from corn contaminated with fusarium, which was named vomitoxin because it caused vomiting symptoms in pigs, and was subsequently found to be isolated from fusarium contaminated barley, gibberellin. Vomitoxin is a common mycotoxin in food, widely existing in nature, and 3 toxins commonly found in europe and north america are deoxynivalenol, 3-acetyldeoxynivalenol, and 15-deoxynivalenol. Because of their highly cytotoxic and immunosuppressive properties, they pose a threat to the health of humans and animals, especially with a significant impact on immune function. Depending on the dose of DON and the exposure time, immunosuppression or immunostimulation may be induced. When people ingest food contaminated by vomitoxin, acute poisoning symptoms such as anorexia, vomiting, diarrhea, fever, unstable standing, and slow response can be caused, and in severe cases, hematopoietic system is damaged to cause death. Because the grain proportion in the traditional Chinese diet habit is greatly higher than that in the west, the harm of vomitoxin is more prominent. In 1998, vomitoxin was listed as a class 3 carcinogen in an evaluation report published by the international cancer research institute. The European Union requires vomitoxin to be less than 1.0 mg/kg; chinese feed requirements are less than 1 ppm.
The vomitoxin has quite common pollution to Chinese grain raw materials and feed products, mycotoxin analysis reports from 2013 to 2019 of Jiangsu Austria feed mycotoxin engineering research center are summarized, 3632 corn samples are analyzed, the detection rate of the vomitoxin is 100%, the average value is 784.6ppm, and the highest value is 3652.3 ppm. And exceeding 53.97 percent. 2864 corn by-product samples were analyzed, and the detection rate of vomitoxin was 100%, the mean value was 1164.8ppm, and the highest value was 4402.7 ppm. And exceeding 76.52 percent. 4481 compound feed samples were analyzed, and the detection rate of vomitoxin was 100%, the mean value was 876.2ppm, and the maximum value was 3346.01 ppm. The standard exceeding rate is 22.35 percent.
The vomitoxin has stable chemical properties, can not be damaged in the processes of processing, storage and cooking generally, can be stored for a long time under the condition of a laboratory, keeps the toxicity unchanged, has stronger heat resistance, and has only a small amount of damage after being heated at the temperature of 121 ℃ for 25min under high pressure. The toxicity of the grain processed product is not influenced by the acidic environment, but the grain processed product containing vomitoxin can be damaged by adding alkali or high-pressure treatment, and the vomitoxin can not be completely removed due to technical limitation in the processing process, is mainly absorbed by gastrointestinal tracts, enters the liver through blood circulation for metabolism, is discharged with urine through the kidney, and causes wide damage to various organs. The half-life period of the vomitoxin in a human body is 2-4 h, the metabolism is rapid, and the vomitoxin and the metabolite thereof cannot be detected after 8 h.
At present, the detoxification method of the mildewed grains and feeds at home and abroad mainly comprises a physical adsorption method, a chemical detoxification method, a biological detoxification method and the like. The physical adsorption method has reversible DON adsorption and poor efficiency, and is easy to adsorb trace nutrient elements, thereby causing the loss of nutrient substances in cereals and feeds; chemical detoxification easily leaves some potential toxic substances, and causes secondary pollution to grains and feeds, so that the DON traditional detoxification method has certain limitation in practical application; the biological detoxification method is characterized in that DON is acted by enzyme released by microorganisms and is converted into a metabolite with lower toxicity, and the microbial degradation has the advantages of low cost, high efficiency, less nutrient loss, no secondary pollution, good ecological restoration and the like, so that great attention is paid.
Disclosure of Invention
The invention aims to solve the technical problem that aiming at the defects in the prior art, the bacillus subtilis AM-05 for efficiently degrading vomitoxin and the application thereof are provided.
The technical scheme for solving the technical problems is as follows:
a bacillus subtilis AM-05 for efficiently degrading vomitoxin is obtained by separating, screening and fermenting bacillus subtilis AM-05 strain in wheat field soil infected with gibberellic disease.
The technical scheme of the invention is further defined as follows:
further, in bacillus subtilis AM-05 capable of efficiently degrading vomitoxin, the preparation method of the strain is as follows:
(I) screening of bacterial species
(1) Taking field soil of wheat infected with gibberellic disease, shoveling off 5cm of the surface layer, taking 5-15 cm of the field soil, sampling by using a sterile instrument, putting the field soil into a sterile plastic bag or a sterile paper bag, binding, separating after sampling, shaking for 20-25min to fully mix a soil sample with water, dispersing cells, putting the sample into a triangular flask filled with 99ml of sterile water, treating the sample in a water bath at normal pressure of 80 ℃ for 1 hour, and taking out;
(2) sucking 1ml of soil suspension from a 1ml sterile pipette, adding into a large test tube containing 9ml of sterile water, mixing, sucking 1ml from the test tube with the sterile pipette, adding into another test tube containing 9ml of sterile water, mixing, and repeating the steps to obtain 10-2、10-3、10-4、10-5Soil solutions of different dilutions;
then using sterile straws respectively 10-3、10-4、10-5Sucking 0.2ml of each of the three tubes of soil diluent, dripping the three tubes of soil diluent at the central position of the surface of the corresponding plate culture medium, coating the three tubes of soil diluent by using a sterile coater, standing the three tubes of soil diluent at room temperature for 5-10min, and immersing the bacteria liquid into the culture medium;
(3) inverting the plate culture medium in the step (2) into an incubator at 30 ℃ for culturing for 1-3 d;
(4) observing the surface of the bacterial colony to be rough and opaque, wherein the bacterial colony is in a dirty white or yellowish color, respectively selecting a few cells from the single bacterial colony of the strain to be inoculated on a seed culture medium, and culturing in an incubator at 30 ℃ to obtain a strain to be selected;
(5) screening the strains to be selected, detecting the degradation capability of vomitoxin, and screening to obtain a strain AM-05 with the highest degradation capability;
(6) supporting the strain culture with 30% glycerol tube, and storing in-80 deg.C refrigerator;
(II) fermentation of the bacterial species
And taking the separated bacillus subtilis AM-05, fermenting step by step, adding into a 15-ton fermentation tank, fermenting for 48 hours, and spray drying to obtain a bacillus subtilis AM-05 product of about 500 hundred million/g.
In Bacillus subtilis AM-05 for efficiently degrading vomitoxin, the preparation method of the culture medium in the step (2) comprises the following steps: peptone: 10-13g, yeast extract: 4-5g, NaCl: 9-12g, soluble starch: 1-2g, agar: 18-20g, using distilled water to fix the volume to 1000mL of 900-.
In the bacillus subtilis AM-05 for efficiently degrading vomitoxin, the preparation method of the culture medium in the step (4) comprises the following steps: bean cake powder: 10-13g, corn flour 1-3g and Na2HPO4:2-3g,(NH4)2SO4:0.8-1.2g,NH4Cl: 0.5-1g, using distilled water to fix the volume to 1000mL of 900-.
In the bacillus subtilis AM-05 for efficiently degrading vomitoxin, a fermentation culture medium required by the step-by-step fermentation in the step (II) comprises the following components in percentage by mass: bean cake powder: 70-80%, corn flour 5-10%, Na2HPO4:1-2%,(NH4)2SO4:0.5-1%,NH4Cl:0.5-1%1g,CaCl21-2%, alpha-amylase: 1-2%, and the sum of the above components is 100%.
The invention also designs an application of the bacillus subtilis AM-05 in degrading the vomitoxin, the bacillus subtilis AM-05 is added into the modified bentonite, then the yeast cell wall is added, and the special detoxicant vomitoxin can be obtained, and then the special detoxicant vomitoxin is mixed with the feed polluted by the vomitoxin;
the weight percentage of the material is as follows: bacillus subtilis AM-05: 10-30%, modified bentonite: 40-60%, yeast cell wall: 5-15%, and the sum of the above components is 100%.
The invention has the beneficial effects that:
the bacillus subtilis is widely distributed in soil and rotten organic matters, is easy to reproduce in the bacillus subtilis extract, has high growth speed and low requirement on nutrition, can efficiently secrete a plurality of proteins and metabolites, does not produce toxins, is a safe microorganism without pathogenicity, is obtained by firstly separating and screening bacillus subtilis AM-05 strain in the soil of wheat fields infected with gibberellic disease, and can efficiently degrade vomitoxin.
The microbial strain AM-05 with good DON degradation performance is obtained by separation and purification, and the screening, separation and purification technology is simple.
The strain has good stability for degrading DON, can be passaged in an optimized culture medium for 8 generations, has DON degradation rate of over 90 percent, and can effectively relieve the harm of vomitoxin proved by animal experiments.
The detoxifying agent vomit-ling applied by the bacillus subtilis AM-0 provided by the embodiment of the invention improves the growth performance of piglets, the detoxifying agent utilizes the bacillus subtilis to realize biological adsorption, and simultaneously, the yeast cell wall can be combined with mycotoxin to realize biological adsorption, so that the mycotoxin in the feed can be effectively removed.
Detailed Description
Example 1
In the embodiment, through separation and screening, bacillus subtilis AM-05 capable of efficiently degrading vomitoxin is obtained through separation, screening and fermentation from wheat field soil infected with gibberellic disease, and the specific preparation method is as follows:
(I) screening of bacterial species
(1) Taking wheat field soil infected with gibberellic disease, shoveling off 5cm of the surface layer, taking 5-15 cm of the wheat field soil, sampling according to the standard by using a sterile appliance, putting the wheat field soil into a sterile plastic bag or a sterile paper bag, binding, recording sampling time, sampling place, sampling environment and the like for examination, separating as soon as possible after sampling, shaking for twenty minutes to fully mix a soil sample and water, dispersing cells, putting the mixture into a triangular flask containing 99ml of sterile water, treating the sample in a water bath at normal pressure of 80 ℃ for 1 hour, and taking out;
(2) sucking 1ml of soil suspension from a 1ml sterile pipette, adding into a large test tube containing 9ml of sterile water, mixing, sucking 1ml from the test tube with the sterile pipette, adding into another test tube containing 9ml of sterile water, mixing, repeating the steps, and making into 10-2、10-3、10-4、10-5Soil solutions of different dilutions;
then using sterile straws respectively 10-3、10-4、10-50.2ml of each soil diluent is absorbed by each of the three pipes, the three pipes are dripped at the central position of the surface of the corresponding plate culture medium, the three pipes are coated by an aseptic coater, the aseptic coater is held by the right hand and is horizontally placed on the surface of the plate culture medium, the bacterial suspension is slightly expanded outwards along the direction of a concentric circle to be uniformly distributed, and the three pipes are kept stand for 5-10min at room temperature to ensure that the bacterial liquid is immersed in the culture medium;
(3) inverting the plate culture medium in the step (2) into an incubator at 30 ℃ for culturing for 1-3 d;
(4) observing that the surfaces of bacterial colonies are rough and opaque and are in dirty white or yellowish colors, respectively picking a small amount of cells from single bacterial colonies of the strains to inoculate the single bacterial colonies on a seed culture medium, culturing the single bacterial colonies in an incubator at 30 ℃ to obtain strains to be selected, and if the mixed bacteria are found, separating and purifying again; if the strain can not be better observed by naked eyes, gram staining is carried out on the strain, and the strain is observed under a microscope and compared with a standard strain;
identification of isolated strains
(a) Colony morphology identification
Selecting a fresh single colony of AM-05 cultured for 18-24 h for gram staining, observing the physiological morphology of a strain under a microscope, inoculating the single colony into an inorganic salt culture medium for overnight culture, centrifuging at 5000r/min for 5min, then discarding the supernatant, suspending the strain with distilled water, centrifuging at 5000r/min for 5min, repeating the operation once, discarding the supernatant, then suspending the strain with 2mL of sterile distilled water, freeze-drying to obtain strain powder, and observing by using a scanning electron microscope;
the AM-05 provided by the invention has the following morphological characteristics: after the strain is cultured on an LB flat plate at 37 ℃ for 24 hours, the colony is circular, the diameter is 1-2mm, the edge is neat, the surface is moist and glossy, and the colony is gray; observing under a microscope through gram staining, wherein the strain is a gram-negative bacterium, the shape of the strain is short rod-shaped, freeze-drying the centrifuged thallus, and observing the dried thallus powder by using SEM, wherein under the multiple of 20000 multiplied, the thallus is in the shape of short rod with irregular arrangement, two ends are blunt circles, and the size is 0.5 multiplied by 1-3 mu m.
(2) Analysis of biochemical Properties
The white bacterial strain is subjected to physiological and biochemical identification by referring to a common bacterial strain identification method in 'handbook of bacteria system identification'.
Oxidative fermentation of glucose and other sugar alcohols: and (3) inoculating a fresh single colony cultured for 18-24 hours AM-05 into Hufson and Lifson's culture medium by puncturing, sealing the culture medium with sterilized vaseline paraffin oil, sealing the culture medium with the thickness of 0.5-1 cm to isolate air, simultaneously designing an experimental group without oil sealing to verify the oxidative fermentation type of the strain, culturing the strain at room temperature for 1, 2, 3, 7 and 14 days, observing color change, and respectively replacing glucose with lactose, maltose, mannose, arabinose, fructose, xylose and sucrose to detect the sugar alcohol utilization condition of the strain.
(5) Screening the strains to be selected, detecting the degrading capability of vomitoxin, and screening to obtain the strains with the highest degrading capability;
(6) supporting the strain culture with 30% glycerol tube, and storing in-80 deg.C refrigerator;
(II) fermentation of the bacterial species
And taking the separated bacillus subtilis AM-05, fermenting step by step, adding into a 15-ton fermentation tank, fermenting for 48 hours, and spray drying to obtain a bacillus subtilis AM-05 product of about 500 hundred million/g.
In this example, the method of disposing the medium in step (2): peptone: 10-13g, yeast extract: 4-5g, NaCl: 9-12g, soluble starch: 1-2g, agar: 18-20g, using distilled water to fix the volume to 1000mL of 900-.
In this example, the method for preparing the medium in step (4): bean cake powder: 10-13g, corn flour 1-3g and Na2HPO4:2-3g,(NH4)2SO4:0.8-1.2g,NH4Cl: 0.5-1g, using distilled water to fix the volume to 1000mL of 900-.
In the embodiment, the fermentation medium required for the stepwise fermentation in the step (II) comprises the following components in percentage by mass: bean cake powder: 70-80%, corn flour 5-10%, Na2HPO4:1-2%,(NH4)2SO4:0.5-1%,NH4Cl:0.5-1%1g,CaCl21-2%, alpha-amylase: 1-2%, and the sum of the above components is 100%.
The embodiment also relates to an application of the bacillus subtilis AM-05 in degrading vomitoxin, namely, the bacillus subtilis AM-05 is added into the modified bentonite, and then the yeast cell wall is added, and the mass percentages are as follows: bacillus subtilis AM-05: 10-30%, modified bentonite: 40-60%, yeast cell wall: 5-15%, the sum of the above components is 100%, obtaining the special detoxicant emetic for the vomitoxin, then mixing the detoxicant emetic with the feed polluted by the vomitoxin to effectively degrade the vomitoxin, and no other harmful chemical reagent is added into the feed, so that the change of the flavor of the feed and the loss of the nutritive value can not be caused.
The antidote emetic mixed in the application of the bacillus subtilis AM-05 in the embodiment is subjected to an in vitro and simulated in vivo evaluation method (HPLC method) Q/3201 AOMAI-BIO 10-2013:
1. vomitoxin standard stock solution
Weighing 1.0mg (accurate to 0.01 mg) of standard substance vomitoxin, placing in a 50ml volumetric flask, dissolving with methanol, fixing the volume to 50ml, and storing in a refrigerator at 4 ℃ for later use, wherein the concentration of the standard solution is 20 mug/ml;
2. vomitoxin standard working solution
Accurately transferring a certain amount of vomitoxin standard stock solution, diluting with methanol, and respectively preparing standard working solutions of 0 μ g/ml, 2 μ g/ml, 10 μ g/ml, 15 μ g/ml and 20 μ g/ml;
3. preparation of the samples
Sampling according to GB/T14699.1, selecting 500g of the detoxicant vomit medicine sample, reducing the sample to 100g by a quartile method, uniformly mixing the sample and the sample through a 0.28mm hole sieve, putting the mixture into a closed container, and keeping the mixture away from light and at room temperature for later use;
collecting pig small intestine intestinal chyme, centrifuging at 20000 rpm with a high speed centrifuge, extracting supernatant totally 10ml, and storing in a refrigerator at 4 deg.C for use;
4. preparation of sample solution
When the in vitro method is used for determination: weighing 0.2g (accurate to 0.002 g) of sample, placing the sample in a 100ml volumetric flask, performing double distilled water constant volume (obtaining 2mg/ml adsorbent solution), stirring for 24 hours in the dark under magnetic force, respectively and precisely absorbing 0.25ml adsorbent solution and 0.25ml vomitoxin standard substance with 10 microgram/ml in a 1.5ml centrifuge tube, placing the centrifuge tube on a constant temperature oscillation metal bath for 4 hours in the dark under 37 ℃, performing high-speed centrifugation for 10 minutes at 15000r/min, and taking supernatant fluid to filter for HPLC detection;
when the in vivo method is simulated: weighing 0.2g (accurate to 0.002 g) of sample, placing the sample in a 100ml volumetric flask, sucking 10ml of minced small intestine chyme supernatant, adding the mixture, then using double distilled water to fix the volume (obtaining 2mg/ml of adsorbent solution), stirring the mixture in a dark place and by magnetic force for 24 hours, respectively sucking 0.25ml of adsorbent solution and 0.25ml of 10 microgram/ml vomitoxin standard substance in a 1.5ml centrifugal tube, and placing the centrifugal tube on a constant temperature oscillation metal bath for 4 hours in a dark place at 37 ℃. Centrifuging at high speed of 15000r/min for 10min, collecting supernatant, filtering, and detecting by HPLC.
5. Measurement of
High performance liquid chromatography conditions: a chromatographic column: a C18 column with the length of 150mm, the inner diameter of 4.6mm and the diameter of the filler of 5 μm;
when vomitoxin is measured, the mobile phase is methanol: water =20:80, ultrasonic de-gassing, filtration through 0.45 μm filter membrane;
flow rate: 1ml/min, injection volume: 20 μ L, detection wavelength: vomitoxin 218nm, retention time: 10-15 min;
6. quantitative determination
And (3) standard curve preparation: injecting standard working solution into the chromatographic column, and drawing a standard curve by taking the concentration of the standard working solution as an abscissa and the area value of a chromatographic peak as an abscissa;
and injecting a sample solution into the chromatographic column to obtain a response value of a chromatographic peak area, and calculating the residual quantity of the mycotoxin in the sample solution according to a standard curve graph of the standard solution peak area.
The adsorption rate of the sample solution to the mycotoxin is calculated by the following formula:
X = m 1/ m 0* 100% = (m 0 -m 2)/ m 0* 100%
x: adsorption ratio (%) of the test sample to mycotoxin
m 0, addition amount of mycotoxin
m 1 adsorption amount of mycotoxin
m 2 residual quantity of mycotoxin
Taking the arithmetic mean value of the results of two parallel measurements as the measurement result, wherein the absolute difference value of the results of the parallel measurements does not exceed 0.2 percent of the arithmetic mean value, and the degradation rate of the obtained vomitoxin by the vomitoxin can reach more than 90 percent.
Influence of emetic on growth performance of piglets
In this experiment, 28 weaned piglets (3 weeks old) were selected and randomly allocated to 4 treatment groups, 7 piglets per group, and each piglet was raised in 1 metabolic cage. The group 1 is fed with a Base (BD), the daily ration of the group 1 meets the nutritional requirement of NRC (2012), and the other 3 groups are fed with BD respectively added with 1.0mg/kg DON, 3.0mg/kg DON and 3.0mg/kg DON +0.05% emetolin (the emetolin prepared by the invention).
The experimental groups are shown in table 1:
TABLE 1 test grouping
Group of | Treatment of |
Treatment group 1 | Basic ration (BD, Control) |
Treatment group 2 | Basal Diet (BD) +1mg/kg DON (1.0 DON) |
Treatment group 3 | Basal Diet (BD) +3mg/kg DON (3.0 DON) |
Treatment group 4 | Basal Diet (BD) +3mg/kg DON +0.05% emetic (3.0 DON + A) |
The weekly weight and feed intake of piglets during the test period are recorded, and the daily gain and the feed conversion rate are calculated.
The content of each toxin in the daily ration is shown in table 2 specifically:
TABLE 2 actual content of several toxins in each group of diets1
Control | 1.0 DON | 3.0 DON | 3.0 DON+A | |
DON,mg/kg | <0.1 | 1.022 | 3.124 | 3.201 |
AFB1, mg/kg | 0.002 | 0.005 | 0.071 | 0.050 |
ZEA, mg/kg | <0.01 | 0.071 | 0.598 | 0.531 |
Note: the detection lines of 1DON, AFB1 and ZEA are respectively 100, 0.5 and 10 mug/kg; DON is the HPLC measurement value; AFB1 and ZEA are ELISA measured values; -is not detected.
The growth performance index is shown in table 3:
TABLE 3 influence of emetic toxins and emetics on growth performance of piglets
Control | 1.0 DON | 3.0 DON | 3.0 DON+A | |
Initial body weight, kg | 6.29 ± 0.20 | 6.24 ± 0.17 | 6.56 ± 0.20 | 6.20 ± 0.15 |
1-2 weeks | ||||
Body weight gain, kg | 2.73 ± 0.65a | 1.07 ± 0.39b | 1.08 ± 0.59b | 2.09 ± 0.40ab |
Feed intake, kg | 3.90 ± 0.54a | 2.39 ± 0.30b | 2.41 ± 0.42b | 3.15 ± 0.42ab |
Feed/Gain, g/g | 1.77 ± 0.29 | 2.16 ± 0.43 | 1.77 ± 0.53 | 1.70 ± 0.20 |
3-4 weeks | ||||
Body weight gain, g | 7.08 ± 0.27a | 5.95 ± 0.24b | 4.66 ± 0.59c | 5.50 ± 0.16bc |
Feed intake, g | 10.39 ± 0.42a | 9.31 ± 0.51ab | 7.29 ± 0.93c | 8.66 ± 0.61bc |
Feed/Gain,g/g | 1.47± 0.03 | 1.57 ± 0.07 | 1.56 ± 0.11 | 1.57 ± 0.09 |
1-4 weeks | ||||
Body weight gain, g | 9.81 ± 0.88a | 7.02 ± 0.44b | 5.73 ± 1.17b | 7.59 ± 0.54b |
Feed intake, g | 14.29 ± 0.93a | 11.70 ± 0.75b | 9.70 ± 1.34b | 11.81 ± 0.96ab |
Feed/Gain,g/g | 1.48 ± 0.05a | 1.67 ± 0.05b | 1.98 ± 0.26b | 1.56 ± 0.08ab |
Note: results are expressed as mean ± sem (n = 7), with the difference indicated by the lower case letters on the shoulder marks of the same row being significant (P < 0.05).
As shown in Table 3, the DON added to the diet at 1.0mg/kg was significantly reduced as compared with the control group (P <0.05) piglet body weight gain (16.0-60.8%) and/or feed intake (18.1-38.7%) at 1-2 weeks, 3-4 weeks and 1-4 weeks and significant increase(s) ((16.0-60.8)P <0.05) feed-meat ratio of 1-4 weeks (12.8%). Adding 1 with daily ration.Compared with the group with 0mg/kg DON, the addition of 3.0mg/kg DON in the daily ration can further reduce (P <0.05) piglet 3-4 weeks body weight gain (21.2%) and feed intake (21.7%). It is worth noting that 0.05% of emetic detoxicant is added into the daily ration, so that the harm of 3.0mg/kg DON to the weight gain, feed intake and/or feed conversion ratio of piglets in 1-2 weeks, 3-4 weeks and 1-4 weeks can be effectively relieved, and the emetic effectively improves the growth performance of the piglets, thereby improving the economic benefit.
In addition to the above embodiments, the present invention may have other embodiments. All technical solutions formed by adopting equivalent substitutions or equivalent transformations fall within the protection scope of the claims of the present invention.
In addition to the above embodiments, the present invention may have other embodiments. All technical solutions formed by adopting equivalent substitutions or equivalent transformations fall within the protection scope of the claims of the present invention.
Claims (6)
1. The bacillus subtilis AM-05 for efficiently degrading emetic toxin according to claim 1, wherein: the bacillus subtilis AM-05 strain is obtained by separating, screening and fermenting wheat field soil infected with gibberellic disease.
2. The Bacillus subtilis AM-05 for degrading vomitoxin with high efficiency according to claim 1, which is prepared by the following specific method:
(I) screening of bacterial species
(1) Taking field soil of wheat infected with gibberellic disease, shoveling off 5cm of the surface layer, taking 5-15 cm of the field soil, sampling by using a sterile instrument, putting the field soil into a sterile plastic bag or a sterile paper bag, binding, separating after sampling, shaking for 20-25min to fully mix a soil sample with water, dispersing cells, putting the sample into a triangular flask filled with 99ml of sterile water, treating the sample in a water bath at normal pressure of 80 ℃ for 1 hour, and taking out;
(2) sucking 1ml of soil suspension from a 1ml sterile pipette, adding into a large test tube containing 9ml of sterile water, mixing, sucking 1ml from the test tube with the sterile pipette, adding into another test tube containing 9ml of sterile water, mixing, and repeating the steps to obtain 10-2、10-3、10-4、10-5Soil solutions of different dilutions;
then using sterile straws respectively 10-3、10-4、10-5Sucking 0.2ml of each of the three tubes of soil diluent, dripping the three tubes of soil diluent at the central position of the surface of the corresponding plate culture medium, coating the three tubes of soil diluent by using a sterile coater, standing the three tubes of soil diluent at room temperature for 5-10min, and immersing the bacteria liquid into the culture medium;
(3) inverting the plate culture medium in the step (2) into an incubator at 30 ℃ for culturing for 1-3 d;
(4) observing the surface of the bacterial colony to be rough and opaque, wherein the bacterial colony is in a dirty white or yellowish color, respectively selecting a few cells from the single bacterial colony of the strain to be inoculated on a seed culture medium, and culturing in an incubator at 30 ℃ to obtain a strain to be selected;
(5) screening the strains to be selected, detecting the degrading capability of vomitoxin, and screening to obtain the strains with the highest degrading capability;
(6) supporting the strain culture with 30% glycerol tube, and storing in-80 deg.C refrigerator;
(II) fermentation of the bacterial species
And taking the separated bacillus subtilis AM-05, fermenting step by step, adding into a 15-ton fermentation tank, fermenting for 48 hours, and spray drying to obtain a bacillus subtilis AM-05 product of about 500 hundred million/g.
3. The bacillus subtilis AM-05 for efficiently degrading emetic toxin according to claim 2, wherein: the preparation method of the culture medium in the step (2) comprises the following steps: peptone: 10-13g, yeast extract: 4-5g, NaCl: 9-12g, soluble starch: 1-2g, agar: 18-20g, using distilled water to fix the volume to 1000mL of 900-.
4. The bacillus subtilis AM-05 for efficiently degrading emetic toxin according to claim 2, wherein: the preparation method of the culture medium in the step (4) comprises the following steps: bean cake powder: 10-13g, corn flour 1-3g and Na2HPO4:2-3g,(NH4)2SO4:0.8-1.2g,NH4Cl: 0.5-1g, using distilled water to fix the volume to 1000mL of 900-.
5. The bacillus subtilis AM-05 for efficiently degrading emetic toxin according to claim 2, wherein: the fermentation medium required by the step-by-step fermentation in the step (II) comprises the following components in percentage by mass: bean cake powder: 70-80%, corn flour 5-10%, Na2HPO4:1-2%,(NH4)2SO4:0.5-1%,NH4Cl:0.5-1%1g,CaCl21-2%, alpha-amylase: 1-2%, and the sum of the above components is 100%.
6. Use of bacillus subtilis AM-05 according to any one of claims 1 to 5 for the degradation of emetic toxin, wherein: firstly adding bacillus subtilis AM-05 into the modified bentonite, then adding yeast cell walls to obtain the special detoxicant emetic for the vomitoxin, and then mixing the detoxicant emetic with the feed polluted by the vomitoxin;
the weight percentage of the material is as follows: bacillus subtilis AM-05: 10-30%, modified bentonite: 40-60%, yeast cell wall: 5-15%, and the sum of the above components is 100%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011470276.8A CN112458026A (en) | 2020-12-15 | 2020-12-15 | Bacillus subtilis capable of efficiently degrading vomitoxin and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011470276.8A CN112458026A (en) | 2020-12-15 | 2020-12-15 | Bacillus subtilis capable of efficiently degrading vomitoxin and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112458026A true CN112458026A (en) | 2021-03-09 |
Family
ID=74804171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011470276.8A Pending CN112458026A (en) | 2020-12-15 | 2020-12-15 | Bacillus subtilis capable of efficiently degrading vomitoxin and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112458026A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113699077A (en) * | 2021-09-08 | 2021-11-26 | 河南工业大学 | Microbial degradation method of vomitoxin |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103243047A (en) * | 2013-05-09 | 2013-08-14 | 中国农业大学 | Bacillus subtilis capable of effectively degrading vomitoxin and application of bacillus subtilis |
CN106509590A (en) * | 2016-10-26 | 2017-03-22 | 北京科润生科技发展有限公司 | Detoxification agent for vomitoxin in biodegradable feed and preparation technology thereof |
CN108251324A (en) * | 2016-12-29 | 2018-07-06 | 中粮营养健康研究院有限公司 | One bacillus subtilis, the microbial inoculum containing the bacterium and its application, the method and kit of vomitoxin of degrading |
CN109593665A (en) * | 2017-09-30 | 2019-04-09 | 中粮营养健康研究院有限公司 | The method of bacillus subtilis, the microbial inoculum containing the bacterium and kit and their application and degradation vomitoxin |
-
2020
- 2020-12-15 CN CN202011470276.8A patent/CN112458026A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103243047A (en) * | 2013-05-09 | 2013-08-14 | 中国农业大学 | Bacillus subtilis capable of effectively degrading vomitoxin and application of bacillus subtilis |
CN106509590A (en) * | 2016-10-26 | 2017-03-22 | 北京科润生科技发展有限公司 | Detoxification agent for vomitoxin in biodegradable feed and preparation technology thereof |
CN108251324A (en) * | 2016-12-29 | 2018-07-06 | 中粮营养健康研究院有限公司 | One bacillus subtilis, the microbial inoculum containing the bacterium and its application, the method and kit of vomitoxin of degrading |
CN109593665A (en) * | 2017-09-30 | 2019-04-09 | 中粮营养健康研究院有限公司 | The method of bacillus subtilis, the microbial inoculum containing the bacterium and kit and their application and degradation vomitoxin |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113699077A (en) * | 2021-09-08 | 2021-11-26 | 河南工业大学 | Microbial degradation method of vomitoxin |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108251324B (en) | Bacillus subtilis, microbial inoculum containing bacillus subtilis, application of microbial inoculum, method for degrading vomitoxin and kit | |
CN108251323B (en) | Bacillus licheniformis, microbial inoculum containing bacillus licheniformis, application of microbial inoculum, method for degrading vomitoxin and kit | |
Schatzmayr et al. | Investigation of different yeast strains for the detoxification of ochratoxin A | |
CN110878265B (en) | Bacillus subtilis for degrading aflatoxin and application thereof | |
CN114134075B (en) | Bacillus bailii capable of producing complex enzyme with high yield and simultaneously degrading mycotoxin with high efficiency and application thereof | |
CN106381277B (en) | Method for removing aflatoxin B1 by using bacillus licheniformis enzyme preparation | |
CN105255759B (en) | One plant of aflatoxin and the difunctional degradation bacteria of ochratoxin and its application | |
Nguyen et al. | Biocontrol of Fusarium verticillioides using organic amendments and their actinomycete isolates | |
CN115895934B (en) | Bacillus bailii for simultaneously degrading vomitoxin and zearalenone and application thereof | |
CN114703096A (en) | Bacillus belgii and fermented feed degrading microbial toxin and application thereof | |
CN105255775A (en) | Solimonas capable of efficiently degrading aflatoxin B1 and application thereof | |
CN111808765A (en) | Bacillus subtilis capable of efficiently degrading vomitoxin and application thereof | |
CN105255774A (en) | Luteimonas sp for degrading alflatoxin B1 and ochratoxin A and application of luteimonas sp | |
CN101381688B (en) | Bacterial strain capable of degrading mold toxin and formulation preparation method thereof | |
CN109593665B (en) | Bacillus subtilis, microbial inoculum containing bacillus subtilis, kit containing bacillus subtilis, application of bacillus subtilis and kit and method for degrading vomitoxin | |
CN113969243A (en) | Lactobacillus plantarum capable of degrading tannin and application thereof | |
CN101100686A (en) | Water-soluble streptomycete polysaccharide and application thereof | |
CN112458026A (en) | Bacillus subtilis capable of efficiently degrading vomitoxin and application thereof | |
CN110591966A (en) | Environment deodorization composite microbial inoculum and preparation method thereof | |
CN114517170A (en) | Bacillus subtilis for degrading vomitoxin and application thereof | |
CN113999791A (en) | Brucella pseudointermedia for efficiently adsorbing vomitoxin and aflatoxin B1 and application thereof | |
CN111944729B (en) | High-temperature-resistant lactobacillus plantarum microbial inoculum and preparation method and application thereof | |
CN109161500B (en) | Siamese bacillus ZJ-2018-1, mycotoxin degrading microbial inoculum and application | |
CN105154351B (en) | The application of one plant of Rhodococcus sp and its degrading zearalenone | |
CN114456990A (en) | Preparation method of DDGS (distillers dried grains with soluble) as well as fermentation strain and culture medium thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210309 |
|
RJ01 | Rejection of invention patent application after publication |